Most lately, it has been identified that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in very similar locations as classical opioid receptors, it binds into a big selection of endogenous opioids. Unlike most opioid receptors, this receptor functions being a scavenger https://leopoldoa989teu9.blogsidea.com/profile